Jeannine Jorpeland

Jeannine Jorpeland is a seasoned professional with extensive experience in clinical research and facilities coordination. Currently serving as a Clinical Research Project Specialist at XBiotech USA Inc. since 2013, Jeannine has contributed to the development of biological therapies, including overseeing multiple Phase I/II/III clinical trials for the lead product candidate Xilonix™, a therapeutic antibody targeting IL-1α. Prior to this role, Jeannine worked at CarboMedics from July 1992 to January 2009 as a Facilities Coordinator, demonstrating a strong foundation in operational support within the medical industry.